Securities code: 603858 securities abbreviation: Shandong Buchang Pharmaceuticals Co.Ltd(603858) Announcement No.: 2022-001 Shandong Buchang Pharmaceuticals Co.Ltd(603858)
Announcement on the marketing license of Xuanfei Baidu granule in Canada
The company and all members of the board of directors guarantee that there are no false records, misleading statements or major omissions in the contents of the announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of the contents.
Xianyang step Trading Development Co., Ltd. (formerly known as Xianyang step Medicine Co., Ltd.), a wholly-owned subsidiary of Shandong Buchang Pharmaceuticals Co.Ltd(603858) (hereinafter referred to as “the company”), recently received a product license for “natural health products” approved and issued by the Canadian Ministry of health. The company’s product Xuanfei septic granules meet the Canadian natural health product standards and are allowed to be listed and sold according to the natural health product standards, The relevant information is disclosed as follows:
1、 Basic information of products
Product Name: Xuanfei Baidu granule
Dosage form: granules
Specification: 10g in each bag (equivalent to 119g of decoction pieces)
Manufacturer: Shandong Buchang Pharmaceuticals Co.Ltd(603858)
Natural health product No.: 80115025
2、 Other information of the product
The main functions of Xuanfei Baidu granule are: dispersing lung and removing dampness, clearing heat and evil, purging lung and detoxifying. It is used for epidemic diseases caused by dampness toxin stagnation of the lung. Symptoms include fever, cough, pharyngeal discomfort, shortness of breath, fatigue, stupidity and poor stool; The tongue is dark red, the coating is yellow and greasy or yellow and dry, and the pulse is slippery or string is slippery.
Xuanfei Baidu granule is the exclusive variety newly approved for listing by the company in 2021. At present, it has been produced according to law and has not been listed for sale yet. 3、 Impact on listed companies and risk tips
This Xuanfei Baidu granule has obtained the product license of “natural health products” approved and issued by the Ministry of health of Canada, which indicates that the company has the qualification to sell the product in the Canadian market, which will have a positive impact on the company’s market expansion, and the company will actively promote the market sales of the product.
The subsequent production and sales of the product are vulnerable to some uncertain factors. The company will actively carry out relevant work according to the requirements. Please make careful decisions and pay attention to preventing investment risks.
It is hereby announced.
Shandong Buchang Pharmaceuticals Co.Ltd(603858) board of directors January 1, 2022
